$GMEX

GMEX Robotics Corp

CIK:0001928581|SEC Filings

Consolidated Statements of Operations and Comprehensive Loss - USD ($)	12 Months Ended
	Jun. 30, 2025	Jun. 30, 2024
Revenues:
Total revenues	$ 5,200,138	$ 4,466,775
Cost of goods sold	(3,157,996)	(2,881,060)
Gross profit	2,042,142	1,585,715
Operating expenses:
Consulting fees	619,108	5,468,126
General and administrative expenses	1,138,266	2,452,954
Personnel expenses	1,195,958	951,451
Sales and marketing expenses	416,596	351,298
Operating lease expense	303,869	284,169
Licensing fees		65,839
Depreciation expense	9,467	10,385
Total operating expenses	3,683,264	9,584,222
Loss from operations	(1,641,122)	(7,998,507)
Other income (expenses):
Change in fair value of warrants	2,024,942
Loss on extinguishment of warrants	(285,346)
IPO related expenses	(600,000)	(50,523)
Unrealized loss on investments		(354,781)
Realized gain on investments	50,675
Other income	44	121,889
Interest income	215,586	2,574
Interest expense	(114,006)	(1,242,140)
Total other incomes (expenses)	1,291,895	(1,522,981)
Loss before taxes	(349,227)	(9,521,488)
Income tax expense (benefit)	333,497	(209,343)
Net loss	(682,724)	(9,312,145)
Foreign currency translation adjustment	3,518	(13,673)
Comprehensive loss	$ (679,206)	$ (9,325,818)
Basic loss per share on net loss	$ (0.53)	$ (10.63)
Diluted loss per share on net loss	$ (0.53)	$ (10.63)
Weighted average shares outstanding - basic	1,277,346	876,266
Weighted average shares outstanding - diluted	1,277,346	876,266
Merchandise Revenue [Member]
Revenues:
Total revenues	$ 5,200,138	$ 3,956,962
Sales of Consumable Products [Member]
Revenues:
Total revenues		358,536
Revenue From Licensing Customers [Member]
Revenues:
Total revenues		$ 151,277

Consolidated Statements of Cash Flows - USD ($)	12 Months Ended
Consolidated Statements of Cash Flows - USD ($)	Jun. 30, 2025	Jun. 30, 2024
Cash Flows from Operating Activities
Net loss	$ (682,724)	$ (9,312,145)
Adjustments to reconcile net loss to net cash from operating activities:
Change in fair value of warrants	(2,024,942)
Loss on extinguishment of warrants	285,346
Depreciation	9,467	10,385
Amortization of right of use assets	303,869	284,169
Valuation allowance for deferred tax asset	342,122
Bad debt provision		579,265
Unrealized loss on investments		354,781
Realized gain on investments	(50,675)
Amortization of debt discount		1,108,088
Stock issued for services		37
Changes in operating assets and liabilities
Accounts receivable	(184,493)	(449,210)
Inventory, at cost	(602,836)	(1,914,007)
Capital receivables of convertible notes	1,472,000
Deposits and other current assets	2,890	(303,457)
Prepaid offering costs	600,000	(1,999,475)
Deferred tax asset		(209,768)
Accounts payable and accrued expenses	(96,647)	42,233
Deferred revenue	126,856	(29,251)
Income tax payable	(212,094)	(77,377)
Accrued employee benefits, non-current	10,657	3,090
Operating lease liability	(315,186)	(340,897)
Net cash from activities	(1,016,390)	(12,253,539)
Cash Flows from Investing Activities
Sales of investments	175,638
Investment in note receivable		(2,500,000)
Net cash from investing activities	175,638	(2,500,000)
Cash Flows from Financing Activities
Net activity on due to related parties	(23,525)	14,422
Funds raised in IPO, gross		13,614,983
Funds raised in Registered Direct Offering, gross	3,496,303
Funds raised in note payables, net	212,679	1,840,000
Repurchase of warrants	(896,415)
Net cash from financing activities	2,789,042	15,469,405
Foreign currency translation adjustment	3,518	(13,673)
Change in cash and cash equivalents	1,951,808	702,193
Cash and cash equivalents at beginning of period	939,014	236,821
Cash and cash equivalents at end of period	2,890,822	939,014
Supplemental Cash Flow Information
Cash paid for interest
Cash paid for income taxes	243,294	247,313
Non-Cash Investing and Financing Activities
Warrants issued to investor	2,569,320
Warrants issued to placement agent	119,902
Capital receivable of convertible notes		1,472,000
Operating lease liability and right of use asset		836,697
Conversion of debt to equity		3,600,000
Conversion of warrants of convertible notes to equity		820,088
Conversion of underwriter’s warrant to equity		$ 37

Consolidated Balance Sheets - USD ($)	Jun. 30, 2025	Jun. 30, 2024
Current assets
Cash and cash equivalents	$ 2,890,822	$ 939,014
Investment in marketable securities		124,963
Accounts receivable, net	242,079	60,042
Inventory, at cost	3,042,629	2,439,793
Capital receivables of convertible notes		1,472,000
Note receivable	2,500,000	2,500,000
Deposits and prepaids	313,979	316,869
Prepaid offering costs	600,000	1,200,000
Total current assets	9,589,509	9,052,681
Property and equipment, net	20,122	27,133
Operating right of use asset, net	287,322	557,798
Deferred tax asset, net		342,122
Brand names	337,504	337,504
Goodwill	1,161,052	1,161,052
Total assets	11,395,509	11,478,290
Current liabilities
Accounts payable and accrued expenses	1,326,988	1,210,956
Deferred revenue	335,956	209,100
Income tax payable	196,587	408,681
Current portion of operating lease liability	286,378	278,432
Total current liabilities	2,161,192	2,145,977
Accrued employee benefits, non-current	32,177	21,520
Operating lease liability, less current portion	12,182	301,921
Total liabilities	2,205,551	2,469,418
Commitments and contingencies (Note 11)
Stockholders’ equity:
Additional paid-in capital	19,874,591	19,014,389
Accumulated other comprehensive loss	(10,219)	(13,737)
Accumulated deficit	(10,676,516)	(9,993,792)
Total stockholders’ equity	9,189,958	9,008,872
Total liabilities and stockholders’ equity	11,395,509	11,478,290
Common Class A [Member]
Stockholders’ equity:
Common stock, value	2,102	2,012
Common Class B [Member]
Stockholders’ equity:
Common stock, value
Related Party [Member]
Current liabilities
Due to related parties	$ 15,283	$ 38,808